These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25752181)

  • 1. A public health approach to global management of hypertension.
    Angell SY; De Cock KM; Frieden TR
    Lancet; 2015 Feb; 385(9970):825-7. PubMed ID: 25752181
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic heart drugs as good as brand names. "You get what you pay for" doesn't apply to prescription drugs.
    Harv Heart Lett; 2009 Feb; 19(6):3. PubMed ID: 19575519
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive treatment - navigating between cost, compliance and complications.
    Conen D
    Swiss Med Wkly; 2013; 143():w13857. PubMed ID: 24163056
    [No Abstract]   [Full Text] [Related]  

  • 5. Substandard drugs among five common antihypertensive generic medications: an analysis from 10 African countries.
    Macquart de Terline D; Diop BI; Bernard M; Do B; Ikama MS; N'guetta R; Balde DM; Tchabi Y; Sidi Aly A; Ali Toure I; Zabsonre P; Damorou JF; Takombe JL; Narayanan K; Fernandez C; Tafflet M; Plouin PF; Empana JP; Marijon E; Jouven X; Antignac M
    J Hypertens; 2018 Feb; 36(2):395-401. PubMed ID: 28957849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to Antihypertensive Drugs in China.
    Bai G; Bennet C; Wang J; Anderson GF
    Circulation; 2018 Oct; 138(17):1777-1779. PubMed ID: 30354658
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-hypertensive medication access and affordability and their association with blood pressure control at a teaching hospital in Ghana.
    Harrison MA; Marfo AFA; Opare-Addo MNA; Ankrah DNA; Acheampong F; Nelson F; Buabeng KO
    Pan Afr Med J; 2021; 39():184. PubMed ID: 34584609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Generic drugs and the consumption trends of antihypertensives in Morocco].
    Berrada El Azizi G; Ahid S; Ghanname I; Belaiche A; Hassar M; Cherrah Y
    Therapie; 2013; 68(5):303-12. PubMed ID: 24225041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicine prices and availability in the Brazilian Popular Pharmacy Program.
    Pinto Cdu B; Miranda ES; Emmerick IC; Costa Ndo R; Castro CG
    Rev Saude Publica; 2010 Aug; 44(4):611-9. PubMed ID: 20585741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of hypertension. Cost conscious prevention of complications].
    Kolloch RE
    MMW Fortschr Med; 2003 Nov; 145(47):64. PubMed ID: 14725042
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessing step-therapy programs:a step in the right direction.
    Gleason PP
    J Manag Care Pharm; 2007 Apr; 13(3):273-5. PubMed ID: 17407393
    [No Abstract]   [Full Text] [Related]  

  • 12. [Health care too costly? Saving more than 10 million euros in 2 months!].
    Rappert B
    MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on the 2017 ACC/AHA interventions for high blood pressure with particular reference to middle- and low-income countries.
    Barrera L
    Eur J Prev Cardiol; 2018 Jun; 25(9):902-905. PubMed ID: 29726714
    [No Abstract]   [Full Text] [Related]  

  • 14. [Do generic drugs help control expenditure on hypertension? Apropos of a case].
    García AJ; Martos F; Martín A; Sánchez F
    Gac Sanit; 2004; 18(2):137-44. PubMed ID: 15104975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic ARBs are coming.
    Harv Heart Lett; 2010 Jul; 20(11):6. PubMed ID: 20815090
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment.
    Costa FV
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):265-274. PubMed ID: 28695464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of implementing recommendations on hypertension management given in recent guidelines.
    Zanchetti A
    J Hypertens; 2003 Dec; 21(12):2207-9. PubMed ID: 14654733
    [No Abstract]   [Full Text] [Related]  

  • 18. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control.
    Misra A; Bloomgarden Z
    J Diabetes; 2020 Jul; 12(7):556-557. PubMed ID: 32419360
    [No Abstract]   [Full Text] [Related]  

  • 20. Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis.
    Wisløff T; Selmer RM; Halvorsen S; Fretheim A; Norheim OF; Kristiansen IS
    BMC Cardiovasc Disord; 2012 Apr; 12():26. PubMed ID: 22475076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.